Proteorex Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Proteorex Therapeutics General Information

Description

Provider of a biotechnology platform created to develop oncology drugs. The company develops oncology drugs using protein-protein interactions (PPIs) between chemical molecule peptides via its proprietary biotechnology platform, enabling physicians and researchers to rapidly and cost-effectively unlock previously undruggable targets.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • MaRS West Tower
  • 661 University Avenue, Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Proteorex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Nov-2017 0000 Completed Out of Business
3. Accelerator/Incubator 25-May-2017 00000 0000 Completed Startup
2. Accelerator/Incubator 11-May-2016 $50K Completed Startup
1. Accelerator/Incubator $50K $50K Completed Startup
To view Proteorex Therapeutics’s complete valuation and funding history, request access »